Infinitopes Secures Approval for Groundbreaking Cancer Vaccine Clinical Trial in the UK#United_Kingdom#Oxford#Infinitopes#Oesophageal_Cancer#ITOP1
Infinitopes Secures Approval for Groundbreaking Cancer Vaccine Clinical Trial in the UK
Infinitopes Ltd has received UK regulatory approval to commence clinical trials for ITOP1, a novel vaccine targeting oesophageal cancer, showing promise in reducing recurrence rates.
third-news.com
April 9, 2025 at 7:36 AM
Infinitopes Secures Approval for Groundbreaking Cancer Vaccine Clinical Trial in the UK#United_Kingdom#Oxford#Infinitopes#Oesophageal_Cancer#ITOP1